These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1685572

  • 1. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF, Laux G, Schubert H, Beckmann H, Amman J, Bunse J, Eikmeier G, Geretsegger C, Kanitz RD, Kanzow WT.
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [Abstract] [Full Text] [Related]

  • 2. A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
    Pflug B, Bartels M, Bauer H, Bunse J, Gallhofer B, Haas S, Kanzow WT, Klieser E, Küfferle B, Stein D.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():142-6. PubMed ID: 1978475
    [Abstract] [Full Text] [Related]

  • 3. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA, Westenberg HG.
    Psychopharmacol Bull; 1990 Sep; 26(1):99-107. PubMed ID: 1973547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH, Wieselgren IM, Struwe G, Kristjansson E, Akselson S, Arthur H, Andersen T, Lindgren S, Norman O, Naimell L.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():130-5. PubMed ID: 1978472
    [Abstract] [Full Text] [Related]

  • 6. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
    Mendlewicz J, de Bleeker E, Cosyns P, Deleu G, Lotstra F, Masson A, Mertens C, Parent M, Peuskens J, Suy E.
    Acta Psychiatr Scand Suppl; 1990 Sep; 358():138-41. PubMed ID: 1978474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
    Widerlöv E, Franzén G, Jansson P, Movin G.
    Int Clin Psychopharmacol; 1990 Apr; 5(2):125-34. PubMed ID: 1974271
    [Abstract] [Full Text] [Related]

  • 9. Once-daily controlled release remoxipride is equieffective with twice-daily immediate release remoxipride in the treatment of schizophrenia.
    Alexander MS, Chakravarti SK, Sundararajan K, Mullin JM, Shaw SH, Blomqvist M, Lockett CM.
    J Psychopharmacol; 1993 Jan; 7(3):276-82. PubMed ID: 22290842
    [Abstract] [Full Text] [Related]

  • 10. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG, Rimön R, Appelberg B, Hagert U, Harma P, Katila H, Mahlanen A, Mehtonen OP, Naukkarinen H, Outakoski J.
    Acta Psychiatr Scand Suppl; 1990 Jan; 358():99-103. PubMed ID: 1978501
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
    den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Acta Psychiatr Scand Suppl; 1990 Jan; 358():108-10. PubMed ID: 1978468
    [Abstract] [Full Text] [Related]

  • 12. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Psychopharmacology (Berl); 1990 Jan; 102(1):76-84. PubMed ID: 1975448
    [Abstract] [Full Text] [Related]

  • 13. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R, Soni S, Rastogi SC, Levine S, Plant I, Edwards JG, Mitchell M, Chanas A.
    Acta Psychiatr Scand Suppl; 1990 Jan; 358():120-4. PubMed ID: 1978470
    [Abstract] [Full Text] [Related]

  • 14. A double-blind multicentre comparison of remoxipride, at two dose levels, and haloperidol.
    Patris M, Agussol P, Alby JM, Brion S, Burnat G, Castelnau D, Deluermoz S, Dufour H, Ferreri M, Goudemand M.
    Acta Psychiatr Scand Suppl; 1990 Jan; 358():78-82. PubMed ID: 1978497
    [Abstract] [Full Text] [Related]

  • 15. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
    Lewander T, Westerbergh SE, Morrison D.
    Acta Psychiatr Scand Suppl; 1990 Jan; 358():92-8. PubMed ID: 1978500
    [Abstract] [Full Text] [Related]

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 17. Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia.
    Tench D, Soni SD, Ashwood T, Movin G.
    Psychopharmacology (Berl); 1990 Dec; 101(1):132-6. PubMed ID: 1971445
    [Abstract] [Full Text] [Related]

  • 18. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
    Delcker A, Schoon ML, Oczkowski B, Gaertner HJ.
    Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
    [Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E, Svestka J.
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [Abstract] [Full Text] [Related]

  • 20. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S, Safarcherati A, Amini H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.